The effect of COVID-19 on pain control in patients with a neurostimulator in situ- a retrospective study
Description
CONCLUSIONS: Infection with SARS-CoV-2, in a significant proportion of patients with an SCS in situ, causes at least a transient deterioration in pain control. Further prospective multicentre studies are indicated to establish the prevalence of this
